Russian Pharmaceutical Industry Leader
27.09.2023
The Pharmasyntez Group presented antiretroviral therapy products at the conference “Topical Issues of HIV Infection in Children”
The Pharmasyntez Group presented antiretroviral therapy products at the conference “Topical Issues of HIV Infection in Children”

"Topical issues of HIV-infection in children" is the theme of the traditional congress, which gathered more than 130 infectious disease physicians from Russia, neighboring and non-CIS countries. The host of the event is the Chief external expert on HIV-infection in children in the Russian Federation, DMedSc, professor Evgeny Evgenyevich Voronin.

The conference was organized for the purpose of experience exchange between specialists fighting with HIV infection in children. For doctors, the question of a steady supply of contemporary medications for the treatment of HIV infection has been and continues to be of utmost importance.

Ravertir® and Raltegra® presented by Pharmasyntez are used in complex therapy in both children and adults, effectively suppressing the effect of HIV and ensuring high quality of life for patients.

“Children living with HIV belong to one of the most vulnerable population groups and need special care and attention. Despite the successes achieved, the arrangement of the issues of HIV-infected children and further improvement of the system of assistance to HIV-infected children and their mothers in Russia remain issues of the extraordinary significance and state concern," emphasized Evgeny Voronin.  


The Pharmasyntez Group of Companies is one of the domestic leaders in the manufacture of HIV drugs, including for children and pregnant women.